Keytruda 100 MG/4 ML vial 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FSCN0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,175
Award facts
- Contract value 100% obligated
- $26,175.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $26,175.48 delivery order to DMS Pharmaceutical Group Inc. on April 14, 2026, for Keytruda 100 mg/4 ml vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).
DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. Ultimate completion date is May 5, 2026. This is a firm fixed-price delivery order issued without set-aside.
Quick answers
Who was awarded contract SPE2DR26FSCN0?
SPE2DR26FSCN0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 14, 2026.
How much is contract SPE2DR26FSCN0 worth?
The government has obligated $26,175 on SPE2DR26FSCN0.
Is contract SPE2DR26FSCN0 an order under another contract?
Yes. SPE2DR26FSCN0 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSCN0 competed?
The extent of competition for SPE2DR26FSCN0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award